Mero-82Homo sapiens (Human)Cancer cell line

Also known as: MERO82

🤖 AI SummaryBased on 2 publications

Quick Overview

Human malignant mesothelioma cell line for cancer research.

Detailed Summary

Mero-82 is a human malignant mesothelioma cell line established from pleural effusions. It exhibits characteristics typical of malignant mesothelioma, including spindle-shaped or epithelial morphology, multinucleate cells, and frequent mitotic figures. The cell line shows variable doubling times, with some lines doubling every 24 hours. Cytogenetic analysis reveals abnormal karyotypes, and the cell line expresses epithelial membrane antigen (EMA), distinguishing it from normal mesothelial cells. Mero-82 is used in research to study the biology of malignant mesothelioma, including genetic alterations, tumorigenicity, and potential therapeutic targets.

Research Applications

Cancer researchMalignant mesothelioma studiesGenetic and cytogenetic analysisTumorigenicity studies

Key Characteristics

Spindle-shaped or epithelial morphologyAbnormal karyotypesExpression of epithelial membrane antigen (EMA)Variable doubling times
Generated on 6/19/2025

Basic Information

Database IDCVCL_2594
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age CategoryUnknown
SexUnknown

Disease Information

DiseasePleural mesothelioma
LineagePleura
SubtypePleural Mesothelioma, Epithelioid Type
OncoTree CodePLEMESO

DepMap Information

Source TypeSigma-Aldrich
Source IDACH-001559_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Leu194Arg (c.581T>G)Unspecified-PubMed=20575032

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,13
D13S317
12
D16S539
12
D18S51
13
D21S11
30
D3S1358
18
D5S818
11,12
D7S820
10
D8S1179
13
FGA
24
Penta D
13
Penta E
11
TH01
9.3
TPOX
8
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.

Asamura H., Gemma A., Yamada T.

J. Thorac. Oncol. 10:844-851(2015).

Establishment of human malignant mesothelioma cell lines.";

Delahaye M., Hagemeijer A.

Int. J. Cancer 44:256-260(1989).